Higher Vedolizumab Trough Levels Associated with Remission in Inflammatory Bowel Disease (IBD) Patients During Maintenance Therapy

被引：0
|
作者：
Ungaro, Ryan [1 ]
Jossen, Jacqueline [1 ]
Phan, Becky [2 ]
Chefitz, Ezra
Jain, Anjali [1 ,3 ]
Naik, Snehal [3 ]
Dubinsky, Marla [4 ]
机构：
[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[2] Icahn Sch Med Mt Sinai, Div Pediat Gastroenterol & Hepatol, New York, NY 10029 USA
[3] Prometheus Labs Inc, San Diego, CA USA
[4] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
来源：
INFLAMMATORY BOWEL DISEASES | 2017年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PD-006
引用
收藏
页码：S7 / S7
页数：1
相关论文
共 50 条
  • [21] Do Vedolizumab trough Levels Predict the Outcome of Subsequent Therapy in Inflammatory Bowel Disease?
    Levartovsky, Asaf
    Cohen, Ido
    Abitbol, Chaya Mushka
    Yavzori, Miri
    Fudim, Ella
    Picard, Orit
    Kopylov, Uri
    Ben-Horin, Shomron
    Ungar, Bella
    BIOMEDICINES, 2023, 11 (06)
  • [22] Vedolizumab levels during induction are associated with long-term clinical and endoscopic remission in patients with inflammatory bowel disease
    Yarur, A.
    Bruss, A.
    Fox, C.
    Beniwal-Patel, P.
    Patel, A.
    Berens, B.
    Naik, S.
    Stein, D.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S64 - S65
  • [23] VEDOLIZUMAB LEVELS DURING INDUCTION ARE ASSOCIATED WITH LONG-TERM CLINICAL AND ENDOSCOPIC REMISSION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Yarur, Andres J.
    Bruss, Alexandra
    Berens, Brandon
    Fox, Caroline
    Beniwal-Patel, Poonam M.
    Patel, Amir
    Ungaro, Ryan C.
    Dubinsky, Marla
    Naik, Snehal
    Stein, Daniel J.
    GASTROENTEROLOGY, 2018, 154 (06) : S827 - S828
  • [24] Do vedolizumab trough levels predict response to consecutive therapy in Inflammatory Bowel Disease?
    Levartovsky, A.
    Cohen, I.
    Abitbol, C. M.
    Yavzori, M.
    Fudim, E.
    Picard, O.
    Kopylov, U.
    Ben-Horin, S.
    Ungar, B.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I451 - I451
  • [25] MAINTENANCE LEVELS OF VEDOLIZUMAB DO NOT CORRELATE WITH CLINICAL REMISSION IN IBD PATIENTS
    Tessolini, Jenna M.
    Bajaj, Girish
    Zezos, Petros
    O'Connell, Jim W.
    Huang, Vivian
    Croitoru, Kenneth
    Steinhart, A. Hillary
    Kelly, Orlaith
    O'Toole, Aoibhlinn
    Kevans, David
    Silverberg, Mark S.
    GASTROENTEROLOGY, 2019, 156 (06) : S1140 - S1140
  • [26] Do vedolizumab trough levels predict response to consecutive therapy in Inflammatory Bowel Disease?
    Levartovsky, A.
    Cohen, I.
    Abitbol, C. M.
    Yavzori, M.
    Fudim, E.
    Picard, O.
    Kopylov, U.
    Ben-Horin, S.
    Ungar, B.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I451 - I451
  • [27] Vedolizumab trough concentrations are associated with endoscopic response in patients with inflammatory bowel disease
    Chao, C. -Y.
    Restellini, S.
    Lemieux, C.
    Germain, P.
    Bitton, A.
    Lakatos, P. L.
    Wild, G.
    Seidman, E.
    Bessissow, T.
    Afif, W.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S367 - S368
  • [28] Serum vedolizumab trough levels are associated with remission rate but not with extra-intestinal manifestations in IBD patients
    Tzadok, R.
    Fliss-Isakov, N.
    Cohen, N. Aviv
    Ron, Y.
    Maharshak, N.
    Hirsch, A.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S441 - S442
  • [29] Early Infliximab Trough Levels Are Associated with Persistent Remission in Pediatric Patients with Inflammatory Bowel Disease
    Singh, Namita
    Rosenthal, Casey J.
    Melmed, Gil Y.
    Mirocha, James
    Farrior, Sharmayne
    Callejas, Silvia
    Tripuraneni, Bhavna
    Rabizadeh, Shervin
    Dubinsky, Marla C.
    INFLAMMATORY BOWEL DISEASES, 2014, 20 (10) : 1708 - 1713
  • [30] Which are the optimal adalimumab trough levels associated with biological remission in patients with inflammatory bowel disease?
    Serra, K.
    Rodriguez-Alonso, L.
    Padulles, N.
    Rodriguez-Moranta, F.
    Arajol, C.
    Gilabert, P.
    Rodriguez, R.
    Bas, J.
    Morandeira-Rego, F.
    Santacana, E.
    Padulles, A.
    Guardiola, J.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S358 - S358
12345